Investment Rating - The report assigns a "Buy-A" investment rating to the company for the first time, with a target price of 6.69 HKD over the next six months [4][3]. Core Insights - The company is positioned as a leading dairy farm in China, benefiting from the anticipated rebound in raw milk prices and beef prices, which is expected to enhance profit elasticity [3][9]. - The report forecasts revenue growth rates of 1.2%, 9.6%, and 12.7% for the years 2025 to 2027, with net profits projected at 0.1 billion, 15.7 billion, and 27.1 billion CNY respectively [3][9]. Summary by Relevant Sections Raw Milk Cycle - By December 2025, raw milk prices have decreased by 31% from their peak in August 2021, marking nearly four and a half years of decline. A rebound is expected in 2026 due to factors such as the aging of the cow herd and the expiration of large powder stocks, which will drive demand for fresh raw milk [1][2]. - The company is expected to benefit significantly from the recovery in raw milk prices, which will enhance its gross profit margins from raw milk sales [1][3]. Beef Cycle - The price of live cattle has also entered a new upward cycle after a decline of 31% from its peak in January 2023 to a low in February 2025. The report anticipates that live cattle prices will continue to rise in 2026, benefiting the company's income from the sale of culled cattle [2][3]. - The company is projected to earn approximately 700 million CNY from the sale of culled cattle in 2024, which will be positively impacted by the rising prices of live cattle [2][3]. Financial Projections - The company is expected to generate revenues of 20.33 billion CNY in 2025, 22.28 billion CNY in 2026, and 25.11 billion CNY in 2027, with corresponding net profits of 0.1 billion, 1.57 billion, and 2.71 billion CNY [8][9]. - The gross margin for raw milk sales is projected to improve from 33.7% in 2025 to 38.1% in 2027, reflecting the company's operational efficiency and favorable market conditions [10][9].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 120 HKD [5] Core Views - The semiconductor industry is experiencing significant asset operations and expansion, with a focus on long-term capacity expansion and supply chain localization. The acquisition of 97.4988% of Huali Micro by the company is expected to enhance its performance and liquidity [1][2] - The integration of Huali Micro is projected to increase the company's net profit by 151%, raising the earnings per share (EPS) by 127% [3] - The company is well-positioned to benefit from the dual drivers of "specialized processes + logic processes," alongside the expansion of 12-inch capacity and technological synergies [1][4] Financial Impact on Balance Sheet - Without considering the financing, the total assets are expected to increase by 7.6% to 933.6 billion RMB, and the net assets will rise by 4.2% to 462.8 billion RMB [2][10] - If the financing is successful, total assets and net assets could increase by 16% and 21%, respectively, potentially pushing total assets beyond 1 trillion RMB [2][10] Financial Impact on Profit and Loss Statement - The acquisition is expected to contribute an additional 5.7 billion RMB to net profit, resulting in a total net profit of 9.6 billion RMB, a 151% increase compared to pre-acquisition figures [3][11] - The EPS is projected to rise from 0.22 RMB to 0.50 RMB, reflecting a significant enhancement in shareholder returns [3][11] Earnings Forecast and Valuation - Revenue forecasts for 2025, 2026, and 2027 are projected to grow by 20.9%, 28.8%, and 17.6%, reaching 24.2 billion, 31.2 billion, and 36.7 billion USD, respectively [4][20] - The company is valued at a price-to-book (PB) ratio of 4.2 times for 2026, reflecting its leading position in specialized processes within the semiconductor industry [4][12]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company announced a share buyback of up to HKD 400 million over five months, reflecting confidence in long-term development [5] - The upcoming holiday season is expected to boost revenue for the core product "Heart Town," with the international version set to launch on January 8, 2026, and has already garnered over one million global pre-registrations [5] - The company is optimistic about growth driven by festive events, regional expansion, and new game launches, with several high-profile mobile and PC games expected to launch in 2026 [5] - The performance of the game "Iser" in the domestic market has led to a downward revision of net profit forecasts for 2025-2027 [5] Financial Summary and Valuation Metrics - Revenue projections are as follows: - 2023: HKD 3,389 million - 2024: HKD 5,012 million - 2025: HKD 6,353 million - 2026: HKD 7,620 million - 2027: HKD 8,441 million - Year-over-year growth rates for revenue are projected at: - 2024: 47.9% - 2025: 26.7% - 2026: 20.0% - 2027: 10.8% [8] - Net profit projections are as follows: - 2023: -HKD 554 million - 2024: HKD 812 million - 2025: HKD 1,507 million - 2026: HKD 2,006 million - 2027: HKD 2,387 million - Year-over-year growth rates for net profit are projected at: - 2024: 1077.3% - 2025: 85.7% - 2026: 33.2% - 2027: 19.0% [8] - The current price-to-earnings (P/E) ratios are projected as follows: - 2025: 20.8 - 2026: 15.6 - 2027: 13.1 [8]

Investment Rating - The investment rating for Geely Automobile is "Buy" and is maintained [6]. Core Insights - Geely Automobile reported December 2025 sales of 237,000 units, representing a year-on-year increase of 12.7% but a month-on-month decrease of 23.7%. The total sales for the year reached 3.025 million units, up 39.0% year-on-year [2][4]. - The company is expected to enter a new product era supported by the GEA architecture, with positive developments across its brands including Zeekr, Lynk & Co, and Galaxy. The transition to new energy vehicles is progressing smoothly, and the scale effects are expected to enhance profitability [2][7]. - Geely's strong foundation in fuel vehicles and innovative overseas expansion strategies are opening new markets. The company is set to accelerate its smart driving capabilities as part of its intelligent strategy [2][7]. Summary by Sections Sales Performance - December 2025 sales were 237,000 units, with year-on-year growth of 12.7% and a month-on-month decline of 23.7%. The breakdown includes 173,000 units from Geely brand, 34,000 from Lynk & Co, and 30,000 from Zeekr, with respective year-on-year changes of +10.2%, +29.4%, and +11.3% [7]. - For the entire year, cumulative sales reached 3.025 million units, with significant contributions from Galaxy (1.236 million units, +149.9%), Lynk & Co (350,000 units, +25.4%), and Zeekr (224,000 units, -1.8%) [7]. Strategic Outlook - Geely aims for total sales of 3.45 million units in 2026, representing a year-on-year increase of 14%. The targets for each brand are 2.75 million for Geely, 400,000 for Lynk & Co, and 300,000 for Zeekr [7]. - The company is focusing on brand strategy, with simultaneous efforts in electrification and intelligence, supported by a strong new vehicle cycle [7]. Financial Projections - The expected net profit for 2025 is 17 billion yuan, with a corresponding price-to-earnings ratio of 10.6x, indicating significant profitability potential [7].

Investment Rating - The report assigns an IPO-specific rating of 5.9 out of 10 for the company, based on operational performance, industry outlook, offering valuation, and market sentiment [7]. Core Insights - The company, founded in 2005, operates under a fabless model focusing on integrated circuit design, with core products including specialized memory chips, MCUs, analog chips, and sensor chips, serving various sectors such as consumer electronics, automotive, and IoT [1]. - The semiconductor industry is characterized by significant cyclicality, with a recovery expected starting in 2024 after a downturn in 2023, driven by uneven market recovery and AI applications [3]. - The company holds leading positions in several market segments, including NOR Flash and SLC NAND Flash, with a strong emphasis on R&D and strategic acquisitions to enhance its product offerings and market presence [4]. Financial Summary - Revenue projections for 2022 to 2025 show a decline from 81.30 billion CNY in 2022 to 57.61 billion CNY in 2023, followed by a recovery to 73.56 billion CNY in 2024, with net profits expected to follow a similar trend [2]. - The gross margin is anticipated to gradually recover to 36.9% by mid-2025, with net asset value increasing to 174.35 billion CNY [2]. Industry Status and Outlook - The semiconductor industry is experiencing a downturn in 2023 due to normalized demand post-pandemic, but signs of recovery are expected in 2024, particularly in AI-driven applications [3]. - The competitive landscape in the NOR Flash, SLC NAND Flash, and niche DRAM markets is concentrated, with the top three players holding significant market shares [3]. Strengths and Opportunities - The company benefits from a strong market position, diverse product matrix, and a robust R&D team, with over 15% of revenue allocated to R&D in 2023-2024 [4]. - The rise of edge AI is expected to create additional demand for the company's products, with strategic acquisitions enhancing its capabilities in the analog chip sector [4]. Weaknesses and Risks - The company faces intense market competition and reliance on third-party manufacturing, which may impact pricing and profitability [5][6]. - High supplier concentration poses risks, as the company depends heavily on a limited number of core partners for production [9].

Investment Rating - The report assigns a rating of "Buy" for the company [5]. Core Insights - The acquisition of Hebei Kangda enhances the company's position in the northern home care market, leveraging dual brand synergy for growth [2][3]. - The company plans to acquire 100% equity of Hebei Kangda for up to 450 million RMB, which is a leading player in the northern home care sector with a strong customer base [9]. - The acquisition is expected to improve the company's competitiveness in the home care category in the northern region, optimizing its industrial layout and enhancing market penetration [9]. Financial Summary - The company forecasts total revenue growth from 1,616 million RMB in 2023 to 2,428 million RMB in 2027, reflecting a compound annual growth rate (CAGR) of approximately 10% [10]. - Net profit is projected to increase from 175 million RMB in 2023 to 278 million RMB in 2027, with a growth rate of 12% [10]. - The company’s earnings per share (EPS) estimates for 2025, 2026, and 2027 are 0.16, 0.19, and 0.21 RMB respectively, with a target price set at 4.35 HKD based on a 25X PE for 2025 [9][10].

Investment Rating - The report assigns a "Buy" rating for the company [7] Core Insights - The company achieved total revenue of 20.38 billion yuan in Q3 2025, a year-on-year increase of 101.8%, with net loss significantly narrowing to 0.38 billion yuan. Total deliveries reached 116,007 units, up 149.3%, marking a historical high. The comprehensive gross margin exceeded 20% for the first time, reaching 20.1%, indicating a notable improvement in profitability [1][4] - The company has launched a "dual power" strategy combining pure electric and range-extended vehicles to address user range anxiety. The first range-extended model, X9 EREV, was launched in November 2025, featuring a 63.3 kWh battery and a conversion efficiency exceeding 3.6 kWh/L, achieving a pure electric range of 452 km. Additional range-extended versions of key models are expected in Q1 2026, alongside four new models in 2026, including two SUVs based on the MONA platform [2] - The company is transitioning from "smart cars" to a "physical AI" company, showcasing its commitment and specific path at the 2025 Technology Day. The core technology, VLA 2.0, enhances reasoning efficiency by 12 times and improves average takeover mileage in complex scenarios by 13 times. The model is set to be fully deployed in Ultra models by Q1 2026 and is expected to extend to robotics and other embodied intelligence fields [3] - The company forecasts revenues of 75.8 billion yuan, 132.1 billion yuan, and 166.3 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 85.4%, 74.3%, and 25.9%. The net profit attributable to the parent company is projected to be -1.55 billion yuan, 2.00 billion yuan, and 6.13 billion yuan for the same years [4][5]

Investment Rating - The report initiates coverage with a rating of "Buy" for MTR Corporation [2][6] Core Insights - MTR Corporation has established itself as the core operator of Hong Kong's rail transit since its inception in 1975, with a significant focus on local line construction and expansion into international markets [5][16] - The "Rail + Property" development model allows MTR to finance railway projects through land development rights granted by the government, which is expected to drive long-term growth as the Hong Kong real estate market recovers [5][47] - The company has a progressive dividend policy, with expected dividends per share increasing from HKD 1.06 in 2015 to HKD 1.31 in 2024, maintaining dividends even during losses [5][43] Financial Data and Profit Forecast - Revenue projections for MTR Corporation are as follows: - 2023: HKD 56,982 million - 2024: HKD 60,011 million - 2025E: HKD 57,117 million - 2026E: HKD 55,584 million - 2027E: HKD 58,152 million - Net profit attributable to shareholders is forecasted as: - 2023: HKD 7,784 million - 2024: HKD 15,772 million - 2025E: HKD 16,203 million - 2026E: HKD 20,166 million - 2027E: HKD 10,138 million - The company is expected to maintain a dividend yield of approximately 4.4% from 2025 to 2027 [4][6] Business Model and Operations - MTR Corporation operates under a "Rail + Property" model, which integrates railway operations with property development to fund infrastructure projects [5][47] - The company is actively involved in multiple new railway and station projects to enhance connectivity in densely populated areas of Hong Kong [51][52] - The Hong Kong rail operations are expected to see a recovery in passenger numbers, with total passenger volume projected to reach 1.953 billion in 2024, recovering towards pre-pandemic levels [79] Valuation and Target Price - The estimated enterprise value of MTR Corporation is HKD 2,766 billion, with a 20% discount applied due to diversified operations, leading to a target equity value of HKD 2,213 billion [6] - The target price is set at HKD 35.55 per share, indicating a potential upside of 19% from the current market value [6]

Investment Rating - The report maintains a "Buy" rating for JD Health with a target price of HKD 77.40 [7][18]. Core Insights - JD Health is expected to continue strong revenue growth in 4Q25, with a projected year-on-year increase of 22.7% to RMB 20.26 billion, driven by the increasing online penetration of pharmaceuticals and the company's competitive advantages in supply chain management [2][15]. - The company is anticipated to achieve a non-IFRS operating profit of RMB 260 million in 4Q25, reflecting a non-IFRS operating profit margin of 1.3%, an improvement of 0.4 percentage points year-on-year [2]. - The report highlights the importance of monitoring the supply iteration of new medical products, the impact of weight-loss drugs entering the medical insurance list, the penetration of AI medical applications, and the expansion of JD Health's O2O business [1]. Revenue and Profit Forecast - JD Health's total revenue for 4Q25 is expected to grow by 22.7% year-on-year to RMB 20.26 billion, with pharmaceuticals projected to see over 30% growth in GMV [2][15]. - For the full year of 2025, revenue is forecasted to increase by 25% to RMB 72.7 billion, with a non-IFRS operating profit of RMB 4.11 billion, corresponding to a non-IFRS operating profit margin of 5.7%, an improvement of 1.2 percentage points year-on-year [2][15]. Offline Business Development - JD Health is set to open over 200 new offline pharmacy stores in the second half of 2025, with 150 stores expected to open in 4Q25, enhancing user reach and brand exposure [3]. - The company's medical insurance payment coverage has expanded to 8 cities, including Shanghai, which is anticipated to drive user penetration and performance growth [3]. New Product Launches and AI Integration - JD Health continues to strengthen partnerships with upstream medical brands, achieving multiple collaborations for new drug launches, thereby enhancing its channel value [4]. - The report notes the positive reception of JD Health's AI doctor, which has achieved a satisfaction rate of 98%, reinforcing its capabilities in internet medical services [4]. Profitability Adjustments - The profit forecasts for 2025-2027 have been raised by 11.6%, 15.6%, and 22.4% respectively, due to improved revenue expectations and the anticipated release of operating leverage [5][15]. - The target valuation for 2026 has been adjusted to a non-IFRS PE of 30.0x, reflecting a premium over comparable companies, driven by JD Health's efficiency in the pharmaceutical market and its advantages in AI medical applications [18].

Investment Rating - The investment rating for the company is "Buy" and it is maintained [6]. Core Insights - The company delivered a total of 37,508 vehicles in December 2025, representing a year-on-year increase of 2.2% and a month-on-month increase of 2.1% [2][4]. - For the entire year of 2025, the company achieved cumulative deliveries of 429,000 vehicles, marking a significant year-on-year growth of 125.9% [2][4]. - The launch of the new X9 model has been particularly strong, with 5,424 units delivered in December, achieving a month-on-month increase of 68% and a year-on-year increase of 289% [6]. - The company is expected to continue its growth trajectory with new models like the P7+ and G7 set to be released, enhancing its sales cycle [6]. - The overseas market has also shown promising growth, with 45,000 vehicles delivered internationally in 2025, reflecting a year-on-year increase of 96% [6]. - The company anticipates Q4 2025 deliveries to be between 125,000 and 132,000 units, which would represent a year-on-year growth of 36.6% to 44.3% [6]. Summary by Relevant Sections Sales Performance - December 2025 deliveries totaled 37,508 vehicles, with a year-on-year growth of 2.2% and a month-on-month growth of 2.1% [2][4]. - Cumulative deliveries for 2025 reached 429,000 vehicles, up 125.9% year-on-year [2][4]. New Product Launches - The X9 model has seen strong performance, with December deliveries reaching 5,424 units, marking a record for the model [6]. - Upcoming releases of the P7+ and G7 models are expected to further boost sales [6]. International Expansion - The company delivered 45,000 vehicles in international markets in 2025, a 96% increase year-on-year [6]. - The company has established a presence in 60 countries and regions globally, with local production in Malaysia starting in December 2025 [6]. Future Outlook - The company is positioned for significant revenue growth, with projected revenues of approximately 75.1 billion and 112.1 billion for 2025 and 2026, respectively [6]. - The anticipated price-to-sales ratios for 2025 and 2026 are 1.8 and 1.2, respectively, supporting the "Buy" rating [6].